SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019268
Filing Date
2022-05-10
Accepted
2022-05-10 16:07:34
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q stok-10q_20220331.htm   iXBRL 10-Q 2104309
2 EX-10.1 stok-ex101_212.htm EX-10.1 1626361
3 EX-31.1 stok-ex311_7.htm EX-31.1 18393
4 EX-31.2 stok-ex312_6.htm EX-31.2 18290
5 EX-32.1 stok-ex321_10.htm EX-32.1 7196
6 EX-32.2 stok-ex322_8.htm EX-32.2 7869
  Complete submission text file 0001564590-22-019268.txt   8365694

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA stok-20220331.xsd EX-101.SCH 46263
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stok-20220331_cal.xml EX-101.CAL 42737
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stok-20220331_def.xml EX-101.DEF 99873
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE stok-20220331_lab.xml EX-101.LAB 305415
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stok-20220331_pre.xml EX-101.PRE 221441
56 EXTRACTED XBRL INSTANCE DOCUMENT stok-10q_20220331_htm.xml XML 1041860
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38938 | Film No.: 22909583
SIC: 2834 Pharmaceutical Preparations